ABSTRACT
Purpose: The study aims to analyse the pre and post-merger performance of selected pharmaceutical companies in India to assess if there are synergic benefits accruing out of the acquisition/merger. Financial performance of the companies is measured through the profit metrics of selected BSE & NSE listed pharmaceutical companies in India. Using a quantitative research approach, the study evaluates key financial performance indicators, including Sales, Earnings Per Share (EPS), Cash Flow from Operations (CFO), and Profit After Tax (PAT), over a six-year period (three years’ pre-acquisition and three years’ post-acquisition). The research employs descriptive statistics and Paired Sample t-Tests to determine whether financial changes post-acquisition are statistically significant at a 90% confidence level.
Methodology: The variables considered are the profit metrics viz., including Sales, Earnings Per Share (EPS), Cash Flow from Operations (CFO), and Profit After Tax (PAT), over a six-year period (three years’ pre-acquisition and three years’ post-acquisition). Secondary data is collected from Money control, Capitaline, Annual reports of companies BSE and NSE websites. The Sample size is 30, i.e., there are 30 events of acquisition/merger between two pharmaceutical companies. The sampling method can be considered as convenience sampling since based on the availability of data for at least three years pre and post-acquisition, the companies were chosen purely based on the availability of such cases which was very limited and the dataset includes both full (100%) and partial acquisitions where the acquiring company gains a majority stake (above 50%), allowing for significant operational and financial influence.
Findings: The findings confirm that Sales and PAT have consistently increased post-acquisition, suggesting that market expansion, revenue synergies, and operational efficiencies contribute positively to financial outcomes. However, EPS and CFO outcomes vary, indicating that financial structuring, integration efficiency, and cost management play a crucial role in determining acquisition success.
Managerial implications: The study emphasizes that successful acquisitions require effective integration, disciplined financial management, and strategic execution. Firms that optimize synergies and maintain strong capital structures tend to achieve better financial results, whereas those facing integration challenges or excessive acquisition costs may struggle to generate expected benefits.333
